Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

PDA Issues Call to Action for Faster Postapproval Changes

August 29, 2016

The Parenteral Drug Association develops program to address barriers to implementation of postapproval changes.

Recipharm Expands Lyophilization Capacity in Italy

August 25, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.

Alcami Expands US API Capacity

August 18, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

CDMO Alcami adds HPAPI capacity and cryogenic capabilities to its Wisconsin facility.

Fresenius Kabi Expands US Sterile Injectables Capacity

August 18, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Fresenius Kabi will add to its generic, sterile injectable manufacturing at its Melrose Park, Illinois site.

Characterizing Microstructural Differences of Semisolid Topical Dosage Forms

August 17, 2016

Piramal to Acquire HPAPI CDMO Ash Stevens

August 16, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.